Zoetis Inc.
—- Market cap
- $31.33B
- Debt
- +$9.04B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 78% equity / 22% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $31.33B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 ·
Decision snapshot: ZTS stock price vs ALHC: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ALHC's multiple
Needs ALHC P/E.
Implied fair value · at ZTS's multiple
Needs EPS (TTM) is negative, ZTS P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ZTS FY 2025 (ended Dec 31, 2025) · ALHC FY 2025 (ended Dec 31, 2025).
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 78% equity / 22% debt
Capital structure 90% equity / 10% debt · EV / Revenue 0.64x · EV / EBITDA 53.89x
ZTS carries the larger enterprise value at $40.37B against $2.53B; ALHC trades on the lower EV / Revenue multiple (0.64x vs 4.26x); ZTS on the lower EV / EBITDA (9.22x vs 53.89x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Zoetis Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ALIGNMENT HEALTHCARE, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
2.71x
1.80x
Net debt / EBITDA
Leverage against operating earnings
—
-5.99x
Cash and equivalents
Liquid reserves on the balance sheet
—
$604.23M
Total debt
Interest-bearing obligations outstanding
$9.04B
$323.18M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
PFIZER INC
ZTS vs PFE
Merck & Co., Inc.
ZTS vs MRK
JOHNSON & JOHNSON
ZTS vs JNJ
ELI LILLY & Co
ZTS vs LLY
Cigna Group
ZTS vs CI
MOLINA HEALTHCARE, INC.
ZTS vs MOH
Elevance Health, Inc.
ZTS vs ELV
CENTENE CORP
ZTS vs CNC
UNITEDHEALTH GROUP INC
ZTS vs UNH
CLOVER HEALTH INVESTMENTS, CORP. /DE
ZTS vs CLOV
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.